CABICabbacis Inc

About Cabbacis Inc (CABI)

Cabbacis Inc (CABI) is a N/A company headquartered in Niagara Falls, NY, United States whose shares trade over-the-counter on the OTCQB tier.

Cabbacis Inc (OTCQB: CABI) wholly owns Cabbacis LLC, a development stage, U.S. federally-licensed, tobacco product manufacturer founded in 2021 and focused on harm reduction products that contain about 95 percent less nicotine than that of leading U.S. cigarette brands. The mission of Cabbacis is to reduce the harm caused by smoking with its proprietary reduced-nicotine iBlend® products in development. The Company’s worldwide patent portfolio includes 34 issued patents and various pending patent applications across the United States, Europe, China, India, Japan, Indonesia, Russia, South Korea, Canada, Australia, New Zealand, Mexico, Brazil and other countries. Cabbacis holds 6 U.S. patents. Reduced-nicotine cigarettes without hemp have been evaluated in dozens of independent studies and contain about 95 percent less nicotine than conventional cigarettes. Results demonstrate, as reviewed in Donny and White 2022, that subjects smoked fewer cigarettes per day, reduced their nicotine dependence and exposure, doubled their quit attempts, and/or increased their number of smoke-free days. The Company believes including hemp flower into reduced-nicotine cigarettes improves sensory characteristics and may potentially improve effectiveness due to the presence of non-THC cannabinoids. ‍ According to Grand View Research, the global tobacco market was estimated at $886 billion in 2023 and is expected to grow at a CAGR of 2.5% from 2024 to 2030.

Products and services

Cabbacis is developing iBlend™ reduced-nicotine cigarettes and vaporizer pods. Both products are predominately tobacco, include hemp and contain about 95 percent less nicotine than that of leading U.S. cigarette brands. The company also stands ready to move forward with reduced-nicotine tobacco cigarettes without hemp.

CABI key facts

Ticker symbol

CABI

Market tier

OTCQB

Headquarters

Niagara Falls, NY, United States

Country of incorporation

US

Year of incorporation

2023

Employees

5

Shares outstanding

6,607,100

Reporting standard

U.S. Reporting: SEC Reporting - Reg A

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2023)

Cabbacis Inc leadership

• Joseph Pandolfino — CEO
• John Charles Manley Jr. — CFO
• Michael Robert Moynihan, PhD — VP, R&D

Explore more: OTCQB stocks · OTC stocks starting with C